Experimental data on ischemic stroke, neonatal hypoxic-ischemic encephalopathy, epilepsy and Alzheimer’s disease indicated that secretoneurin may functionally act as a brain-protective factor [8–11]. The gene discussed is SCG2; the disease is early-onset autosomal dominant Alzheimer disease.